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Tissue morphologyAbstract Objective: In this report, the effects of cynomorium flavonoids on mouse model of per-
imenopausal depression were investigated. Method: 60 ovariectomized female mice were randomly
divided into 6 groups evenly: high, medium and low doses of cynomorium flavonoids groups
(400 mg kg1, 200 mg kg1, 100 mg kg1), Gengnian’an capsule group (675 mg kg1), soy isofla-
vones soft capsule group (250 mg kg1), and model group. Give the corresponding drug five days
after surgery once a day, consecutive thirty days. The model group and control group were given
the water of same volume. The model related groups were applied with different stress for consec-
utive eighteen days. Kill the mice and remove the thymus, spleen, uterus and one hand of brain
when it is 2 h after the last administration in mice of each group. Observe the histological changes
of each group under light microscope. Results: By observing the pathological section, compared
with model group, the pathological changes of the uterus and hypothalamus of mice were signifi-
cantly improved. The thymic cortex markedly thickened, volume of splenic nodule also significantly
increased, and the number of lymphocytes significantly increased (p< 0.01). Simulation results
show that the high dose of cynomorium flavonoids group has the best effective. Conclusion:
Cynomorium flavonoids on mouse uterus, hypothalamus, thymus and spleen lesions have a signif-
icant role in the improvement. Cynomorium flavonoids have a good therapeutic effect on mice with
perimenopausal depression
 2016 Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Perimenopausal depression is a mood disorder that occurs dur-
ing the perimenopause period. They become prone to mood
depression, unresponsiveness, slow thinking, irritability, and
pessimism (Ma, 2013). Nowadays, the incidence of peri-
menopausal depression is on the rise. Over the years, to inves-
tigate the effect of cynomorium flavonoids on a mouse model
of perimenopausal depression is more and more important. In
this report, the effects of cynomorium flavonoids on mouse
model of perimenopausal depression were investigated (Tan,
2014).
Effect of cynomorium flavonoids 323Cynomorium flavonoids are extracted from cynomorium,
which is a succulent perennial herb of a parasitic plant in the
Cynomorium genus, Cynomorium family. They have multiple
functions, such as scavenging free radicals, anti-oxidation,
anti-aging and anti-stress, regulating immune and endocrine
systems, and improving sexual function (Tian and Miao,
2014). In this report, the effects of cynomorium flavonoids
on mouse model of perimenopausal depression were
investigated.
2. Materials
2.1. Animal
KunMing mouse, female, 27–30 g, Provided by Wuhan Exper-
imental Animal Center, Certificate of Quality No.: 00009520.
2.2. Drugs and reagents
Cynomorium flavonoids, extracted by Henan University of
TCM medicine Laboratory, No. 20110303; Gengnian’an cap-
sule, Changchun YingPing Pharmaceutical Co., Ltd., No.
2011020104; Soybean isoflavones Soft capsule, produced by
GARLANDFOND (US) HEALT HLAREER IND.
GROUP.INC, No. 00683209; Chloral hydrate, produced by
Tianjin Kemiou chemical preparation development center,
No. 20111018; and Cefazolin sodium for injection, produced
by Zhuhai Federal Pharmaceutical Co., Ltd., Zhongshan
branch, No. 90801302.
2.3. Instrument
Electronic balance, Produced by Shanghai MinQiao Medical
Instrument Co., Ltd. No. JY601; Electronic analytical balance,
Produced by Ohaus (Shanghai) Ltd. No. AR1140/C.
Electric thermostatic water bath, Produced by Shanghai a
constant Scientific Instrument Co., Ltd. No. HWS12; Intelli-
gent discharge instrument, Produced by Shanghai Institute of
Nuclear Research Institute of the Fourth Ring instrument,
No. Sn-895B.
3. Method
Take 80 mice of Kunming, female mice, 27–30 g, 10 female
mice were randomly divided into control group, and others
made perimenopausal depression: Removing both of the
ovaries, and ligating fallopian tubes (including fat) to make
the mice of perimenopausal depression. They are being intra-
muscular injection cefazolin sodium once a day, for 3 d
(20 u/mL, 0.1 mL each one) to prevent infection. Vaginal
smears examination one by one 5 d after surgery to determine
ovarian removal. Abandon the mice whose smears show
emotional responses (Zhang et al., 2013). 60 ovariectomized
female mice were randomly divided into 6 groups evenly:
large, medium and small dose of cynomorium flavonoids
groups (400 mg kg1, 200 mg kg1, 100 mg kg1, 20 mg kg1,
10 mg kg1, 5 mg kg1), Gengnian’an capsule group
(675 mg kg1, 33.75 mg mL1), Soy isoflavones Soft capsule
group (250 mg kg1, 12.5 mg mL1), and 5 days after surgery.
The volume is 0.2 mL/10 g. Model group and control groupwere given the same volume of water, once a day continuously
30 d. Each cage is with 1 mouse, and there are 9 kinds of stres-
sors in a random application on the mice everyday continu-
ously for 18d and each stimulation cannot be consecutive:
(1) 5 min (160 Hz)horizontal oscillation; (2) swimming in ice
water (4 C, 5 min); (3) heat stress (45 C, 5 min); (4) shake
(1 time/s, 5 min); (5) clip tail (1 min); (6) fasting (24 h); (7) all
night lighting (24 h); (8) prohibition of drinking water (24 h);
and (9) Behavior limitations (6 h). Mice were dissected at
29 days of administration. At the same time, Remove and
weigh thymus, spleen, uterus, and calculate the organ index
(organ index = organ wet weight mg/mice weight). Take the
brain and isolated hypothalamus. Observe the changes of the
structure and morphology of the groups under the light micro-
scope. Data analysis used SPSS 13.0 for statistical treatment l
(Han and Lu, 2012a). Measurement data is represented by
mean ± Standard Deviation ðx sÞ. Single factor analysis of
variance (LSD, SNK) was used in all groups, and Ridit anal-
ysis was used to analyze the level of data.
4. Result
4.1. Effect of the index of viscera in the model mice
From Table 1, Compared with the control group, thymus and
spleen index of model group significantly reduce (p< 0.05),
and Uterine index decreases significantly (p< 0.01). Prove
that the thymus, spleen and uterus tissue of the mouse model
of the peri menopausal syndrome were observed. Compared
with the model group, soybean isoflavone soft capsule group
and gengnianan capsule group can significantly improve the
thymus, spleen and uterus index (p< 0.05); large dose of
cynomorium flavonoids group can significantly increase the
thymus, spleen and uterus index (p< 0.01); middle dose
Cynomorium flavonoids can significantly improve the animal
model of thymus gland, uterus index (p< 0.05), and signifi-
cantly increase the spleen index (p< 0.01); small dose of
Cynomorium flavonoids can obviously increase the thymus
index and spleen index (p< 0.05), and significantly increase
the uterus index (p< 0.01).
4.2. Effects of the morphology of the uterus in the model mice
After Ridit test, it was found that the model group was signif-
icantly more than that in the control group (p< 0.01), and the
model group was successful in the model of peri-menopausal
mice. Ratio, in which the each of the drugs can significantly
improve the mouse uterus pathological changes (p< 0.01),
including large and middle doses of Cynomorium flavonoids
group has the best effect. The pathological sections are seen
in Appendix A (see Table 2).4.3. Effects of the morphology of the hypothalamus in the model
mice of the peri menopausal syndrome
Through Ridit test, Compared with the control group, the
model mice hypothalamus changes prominently (p< 0.01).
Compared with the model group, the drug groups could signif-
icantly improve the mice pathological lesions (p< 0.01),
whose large and middle doses of cynomorium flavonoids
Table 1 Effect of total flavonoids from Cynomorium on perimenopausal disease model of mice spleen, thymus, uterus index ðx sÞ.
Group n Dose
(mg kg1)
Thymus index
(mg g1)
Spleen index
(mg g1)
Uterine index
(mg g1)
Control group 10 – 2.557 ± 0.425* 3.299 ± 0.477* 2.182 ± 0.363**
Model group 10 – 2.062 ± 0.422 2.746 ± 0.265 1.540 ± 0.313
Soy isoflavones soft capsule group 10 250 2.521 ± 0.496* 3.124 ± 0.802* 1.921 ± 0.353*
Gengnian’an capsule group 10 675 2.521 ± 0.476* 2.976 ± 0.618* 1.932 ± 0.337*
Large dose of cynomorium flavonoids group 10 400 2.676 ± 0.488** 3.215 ± 0.402** 2.449 ± 0.604**
Middle dose of cynomorium flavonoids
group
10 200 2.481 ± 0.334* 3.205 ± 0.369** 1.987 ± 0.427*
Small dose of cynomorium flavonoids group 10 100 2.460 ± 0.446* 2.871 ± 0.822* 2.110 ± 0.631**
Note: Compared with the model group.
* p< 0.05.
** p< 0.01.
Table 2 Effect of total flavonoids from Cynomorium on perimenopausal disease model in mouse uterus pathological changes.
Group n Dose (mg kg1) – + ++ +++
Control group 10 – 10 0 0 0
Model group 10 – 0 0 2 8
Soy isoflavones soft capsule group 10 250 0 4 6 0
Gengnian’an capsule group 10 675 0 3 7 0
Large dose of cynomorium flavonoids group 10 400 9 1 0 0
Middle dose of cynomorium flavonoids group 10 200 7 3 0 0
Small dose of cynomorium flavonoids group 10 100 0 3 7 0
‘‘–” uterine endometrial epithelial cells, gland, and muscular layer and serous were normal; ‘‘+” endometrial epithelial cells, gland less atrophy,
muscular layer and serous membrane were normal; ‘‘++” endometrial epithelial cells, glandular atrophy, muscle layer slightly thinner, and
serosa were normal; ‘‘+++” endometrial epithelial cells, gland atrophy, and muscular layer thinning serosal were normal.
Table 3 Effects of the morphology of the hypothalamus in the model mice of the peri menopausal syndrome.
Group n Dose (mg kg1) – + ++ +++
Control group 10 – 10 0 0 0
Model group 10 – 0 0 1 9
Soy isoflavones soft capsule group 10 250 0 6 4 0
Gengnian’an capsule group 10 675 0 4 6 0
Large dose of cynomorium flavonoids group 10 400 9 1 0 0
Middle dose of cynomorium flavonoids group 10 200 6 4 0 0
Small dose of cynomorium flavonoids group 10 100 0 4 6 0
‘‘–‘‘ hypothalamic brain nuclei of cells slurry, cell volume no abnormal change; ‘‘+” in the hypothalamus of cranial nerve nuclei of a few cells
less slurry volume reduction; ‘‘++” hypothalamic brain nuclei of the cytoplasm of some cells reduced volume reduction; ‘‘+++”
hypothalamic brain nuclei of most of the cytoplasm of the cells decreased significantly narrow body.
324 T. Wang et al.group have the best curative effect. The pathological sections
are shown in Appendix B (See Table 3).
4.4. Effects of the morphology of the thymus in the model mice
From Table 4, compared with the control group, there was no
significant difference. With the model group, drug group could
markedly thick thymic cortex (p< 0.01); soy isoflavone
soft capsule group can significantly increase the number of
lymphocytes in the cortex (p< 0.05), high and low doses ofCynomorium flavonoids can significantly improve the number
of lymphocytes in the cortex (p< 0.01). The pathological
sections are shown in Appendix C.
4.5. Effect of the shape of the spleen in the model mice
From Table 5, Compared with the control group, the volume
of spleen in the model group was significantly decreased
(p< 0.01), and the number of lymphocytes decreased signifi-
cantly (p< 0.01), which indicates that the spleen atrophy after
Table 4 Effect of total flavonoids from Cynomorium on perimenopausal disease model of mice thymus pathology ðx sÞ.
Group n Dose (mg kg1) Thymic cortex thickness (lm) Number of cortical lymphocytes
Control group 10 – 26.38 ± 6.45 36.65 ± 12.25
Model group 10 – 31.27 ± 7.36 43.58 ± 15.37
Soy isoflavones soft capsule group 10 250 43.26 ± 5.27** 56.35 ± 12.45*
Gengnian’an capsule group 10 675 38.46 ± 6.12** 47.26 ± 14.26*
Large dose of cynomorium flavonoids group 10 400 43.24 ± 5.12** 57.26 ± 11.27**
Middle dose of cynomorium flavonoids group 10 200 37.36 ± 5.26** 43.12 ± 10.25
Small dose of cynomorium flavonoids group 10 100 46.38 ± 6.38** 63.27 ± 16.28**
Note: Compared with the model group.
* p< 0.05.
** p< 0.01.
Table 5 Effect of cynomorium flavonoids on model mice spleen pathological of perimenopausal disease.
Group n Dose (mg kg1) Spleen summary (lm) Lymphocyte number
Control group 10 – 27.26 ± 3.27** 32.38 ± 10.36**
Model group 10 – 9.28 ± 2.36 11.26 ± 4.25
Soy isoflavones Soft capsule group 10 250 32.24 ± 4.16** 39.26 ± 11.20**
Gengnian’an capsule group 10 675 14.18 ± 3.45** 18.37 ± 5.35**
Large dose of cynomorium flavonoids group 10 400 38.12 ± 5.37** 46.15 ± 11.38**
Middle dose of cynomorium flavonoids group 10 200 27.27 ± 3.16** 31.26 ± 9.25**
Small dose of cynomorium flavonoids group 10 100 36.26 ± 5.25** 43.17 ± 12.36**
Note: Compared with the model group.
* p< 0.05.
** p< 0.01.
Control group HE×100 Model group  HE×100    Soy isoflavones Soft capsule 
group  HE×100     
Gengnian'an capsule 
group  HE×100
Large dose of cynomorium
flavonoids group HE×100   
Middle dose of cynomorium 
flavonoids group HE×100    
Small dose of cynomorium
flavonoids group  HE×100
Figure A1 The pathological tissue of the model mice of perimenopausal decrease.
Effect of cynomorium flavonoids 325the mice were perimenopausal decreases. Compared with the
model group, the dosage of cynomorium flavonoids, Geng-
nian’an capsule group, and soy isoflavone soft capsule group
can significantly increase the volume of splenic nodule(p< 0.01), and significantly increase the number of lympho-
cytes (p< 0.01), and large dose of Cynomorium flavonoids
group has the best effect. The pathological sections are shown
in Appendix D.
Control group HE×100 Model group  HE×100    Soy isoflavones Soft capsule 
group  HE×100     
Gengnian’an capsule 
group  HE×100
Large dose of cynomorium
flavonoids group HE×100   
Middle dose of cynomorium 
flavonoids group HE×100   
Small dose of cynomorium
flavonoids group  HE×100
Figure B1 Hypothalamic pathology of the model mice of perimenopausal decrease.
Control group HE×100 Model group  HE×100    Soy isoflavones Soft capsule 
group  HE×100     
Gengnian'an capsule 
group  HE×100
Large dose of cynomorium
flavonoids group HE×100   
Middle dose of cynomorium 
flavonoids group HE×100   
Small dose of cynomorium
flavonoids group  HE×100
Figure C1 Thymic pathology of the model mice of perimenopausal decrease.
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The effects of receptor metabolism, endocrine, autonomic
nerve and other factors, depend mainly on the physical and
psychological aspects of the body and the psychological
aspects of the abnormal, the mood swings, and the high degree
of depression in patients (Lin et al., 2014). Because estrogen
secretion is leading to abnormal perimenopausal the main
influence factors and stressful life practice are significant fac-
tors of promoting depression (Li et al., 2013), so this experi-
ment takes the removal of both ovaries, then the mice were
continued stress which was made in perimenopausal depres-
sion model (Miao et al., 2016). Due to castrated mice after a
drop in estrogen levels, atrophy of uterus and immunitydecreased through the observation and study of Cynomorium
songaricum flavone on mouse uterus, thymus gland, hypotha-
lamus and spleen influence to explore the therapeutic effect
of C. songaricum flavone of Menopause Depression.
Ancient medical that peri menopausal depression. This is
the kidney, disease lies in the heart, and the uterus, involving
eight and liver and spleen qi, and central link is heart kidney
uterus physiological reproductive axis misalignments (Zhao
et al., 2013). Women enter the peri menopausal period, due
to ovarian function decline, the uterus index decreased, estro-
gen levels decreased, due to estrogen has a role in assimilation,
can promote protein synthesis to make uterine weight, while
the mouse uterine vascular expansion, water intake increased,
the uterine weight and body weight ratio increased, so the
Control group HE×100 Model group  HE×100    Soy isoflavones Soft capsule 
group  HE×100     
Gengnian'an capsule 
group  HE×100
Large dose of cynomorium
flavonoids group HE×100   
Middle dose of cynomorium 
flavonoids group HE×100    
Small dose of cynomorium
flavonoids group  HE×100
Figure D1 Pathological tissue of spleen of the model mice of perimenopausal decrease.
Effect of cynomorium flavonoids 327Chinese traditional medicine by observing the uterus index to
investigate whether the drug has estrogen activity. And the
level of estrogen in blood decreased, the pituitary feedback
mechanism disappeared, so that the normal hypothalamic
pituitary ovarian axis (HPOA) of the imbalance between
(Mo and Ning, 2014), resulting in the body structure and phys-
iological function of the body, which is the most prominent of
the immune system function is significantly decreased (Zhang
et al., 2013), thymus is immune system of the central organs,
and spleen is also an important way to improve immune func-
tion, so the spleen and stomach weakness can cause menstrual
and reproductive changes, but also one of the important fac-
tors leading to the peri menopausal syndrome (Han and Lu,
2012b). Cynomorium water extract of Part III can enhance
CTX immunity inhibition of mouse nonspecific and specific
immunity function (Yu et al., 2012), and has certain protective
effect on immune imbalance body; kidney yang drugs can bal-
ance hormone levels on ovarian axis and gonadal axis can play
a regulatory role (Su et al., 2014). In this experiment, through
the observation of peri Menopause Depression Model, Mice’
tissue morphology changes C. songaricum flavone on peri
menopausal depression treatment effect.
The experimental results show that compared with the
model group, dose of C. songaricum flavone group mice uterus
coefficient was significantly higher than that of Cynomorium
flavonoids that have estrogenic activity; the thymic cortex
markedly thickened, volume of splenic nodule also signifi-
cantly increased, and the number of lymphocytes increased sig-
nificantly, said Ming in C. songaricum flavone can increase the
immunity of the body. In addition to hypothalamic pathology
tissue lesions had significant improvement effect, and the effect
of total flavonoids of high dose group is the best. This study
suggests that Cynomorium flavonoids can effectively improve
the mouse uterus, thymus, spleen and hypothalamic lesions,
perimenopausal mice have significant therapeutic effect and
TCM clinical treatment of depression and antidepressant drug
research provides pharmacological basis, new methods and
new ideas.Acknowledgements
The research work was supported by the National Natural
Science Foundation of China (Grant No. 81274154) and the
Collaborative Innovation Center for the creation of new Tra-
ditional Chinese medicine and genuine regional drug deep pro-
cessing in Henan University of Chinese Medicine (2012) 188-2.
Appendix A
See Fig. A1.
Appendix B
See Fig. B1.
Appendix C
See Fig. C1.
Appendix D
See Fig. D1.
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